Oncology nurses and APPs provide support and can help to facilitate conversations with patients and families during end-of-life care.
La-Urshalar Brock, MSN, CNM, FNP-BC
Advertisement
Articles by La-Urshalar Brock, MSN, CNM, FNP-BC
Olaparib is an oral drug manufactured in 150-mg and 100-mg tablets. Olaparib is taken by mouth, twice daily. It can be taken without or without food.
Advertisement
Latest Updated Articles
Oncology Drug Crash Course: Olaparib (Lynparza)Published: October 24th 2022 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
VCN-01 Plus SOC Improves Survival, Is Safe in Metastatic PDAC
2
Older, Male Patients More Likely to Have CIP, Prospective Study Reveals
3
Buparlisib/Chemo Combo Misses OS Mark in PD-1–Treated Recurrent HNC
4
Ribociclib Plus AI Shows Lasting Benefit in Early HR+, HER2– Breast Cancer
5
